Nursing Management Of The Patient Developing Quadriplegia Due To Neurological Involvement After Covid-19: A Case Report

Year 2023, , 58 - 65, 29.01.2023

Funda Akduran , Bahar Emiroğlu

https://doi.org/10.46310/tjim.1112662

Abstract

COVID-19 first emerged in China, spread quickly, and was declared a pandemic by the World Health Organization. Neurological complications have led to important symptoms in patients diagnosed with COVID-19. These symptoms have substantially affected patients' quality of life, caused them to depend on others, and prolonged their recovery processes with anxiety and hopelessness. In this case report, the care process applied to an individual who developed quadriplegia due to neurological involvement after COVID-19, according to the "Nursing Model Based on Activities of Living", is shared. With effective evidence-based nursing care, the patient's quality of life was improved, existing problems were alleviated, and the patient was protected against complications.

Keywords

COVID-19, quadriplegia, Nursing Model Based on Activities of Living, case report

References

• T.C. Sağlık Bakanlığı COVID-19 Bilgilendirme Platformu. COVID-19 nedir? Available at: https://covid19.saglik.gov.tr/TR-66300/covid-19-nedir-.html. Accessed February 10, 2022 (in Turkish).
• Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. 2020 Aug; 324(8):782-93. doi: 10.1001/jama.2020.12839.
• Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-20. doi: 10.1056/NEJMoa2002032.
• Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020 Apr 1;11(7):995-8. doi: 10.1021/acschemneuro.0c00122.
• Payus AO, Liew Sat Lin C, Mohd Noh M, Jeffree MS, Ali RA. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19). Bosn J Basic Med Sci. 2020 Aug 3;20(3):283-92. doi: 10.17305/bjbms.2020.4860.
• Ucaroglu N, Kaya Ö, Kotan D. Myalgia frequency in patients with COVID-19 and its relationship with creatine kinase levels. Duzce Med J. 2020 Nov 30;22(Suppl 1):S34-8. doi: 10.18678/dtfd.776953.
• Öztürk Ü, Tamam Y. COVID-19 and neurology. Dicle Med J. 2021 Sep 1;48(Suppl 1):S49-54 (in Turkish). doi: 10.5798/dicletip.1004787.
• Kavurmacı M, Demirel BC. COVID-19 and nursing care. J Educ Res Nurs. 2021 Apr 30;18(Suppl 1):S14-9 (in Turkish). doi: 10.5152/jern.2021.71463.
• Çelik S, Karadağ A, eds. Hemşirelik Bakım Planları: Tanılar, Girişimler ve Sonuçlar. 1. baskı. İstanbul: Akademi Yayınları; 2019 (in Turkish).
• Li H, Xue Q, Xu X. Involvement of the nervous system in SARS-CoV-2 infection. Neurotox Res. 2020 Jun;38(1):1-7. doi: 10.1007/s12640-020-00219-8.
• Domingues RB, Mendes-Correa MC, de Moura Leite FBV, Sabino EC, Salarini DZ, Claro I, Santos DW, de Jesus JG, Ferreira NE, Romano CM, Soares CAS. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease. J Neurol. 2020 Nov;267(11):3154-6. doi: 10.1007/s00415-020-09996-w.
• Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020 Jul;87:18-22. doi: 10.1016/j.bbi.2020.03.031.
• Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020 Aug;41(8):1991-5. doi: 10.1007/s10072-020-04547-7.
• Erdoğdu Y, Koçoğlu F, Sevim C. An investigation of the psychosocial and demographic determinants of anxiety and hopelessness during COVID-19 pandemic. J Clin Psy. 2020;23(Suppl 1):S24-37 (in Turkish). doi: 10.5505/kpd.2020.35403.